Google Ventures Invests in Breakthrough Oral Drug Delivery for Biologics

Source: pharmamanufacturing.com

Sep 18, 2013

PRNewswire.com

Rani Therapeutics today announced it has closed its Series B round of funding, led by Google Ventures. InCube Ventures, a life sciences venture fund that invests in breakthrough medical innovations, and VentureHealth, a healthcare crowdfunding portal, also joined the round. 

 

Rani Therapeutics has developed a platform to convert injectable drugs, including TNF-alpha Inhibitors (e.g. adalimumab and etanercept‎) and basal insulin, into pills.  The company has demonstrated double-digit bioavailability in pre-clinical studies. The funding will support the further development of the company's novel approach for the oral delivery of large drug molecules including peptides, proteins, antibodies, RNAi therapies and select vaccines. Read more
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments